Publications by authors named "Autumn D Zuckerman"

Claim this Profile
O
Optimizing maribavir management: The role of health system specialty pharmacies in access, monitoring, and waste reduction.
Dustin R Donald, Autumn D Zuckerman, Kevin Dee, Nicolas Gargurevich, Leena Choi

J Manag Care Spec Pharm· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Putting patients first: Frontline insights on designing and administering manufacturer patient financial support programs.
Autumn D Zuckerman, Chelsea P Renfro, Danielle Bryan, Wendi Owens, Patrick Nichols

Am J Health Syst Pharm· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of an electronic early treatment assessment and monitoring questionnaire for oral anticancer medication.
Tiffany Bui, Brooke Looney, Josh DeClercq, Bridget Lynch, Kristen Whelchel, Autumn D Zuckerman

Am J Health Syst Pharm· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers to growth hormone access in pediatric patients at an academic medical center.
Chardé Parrish, Danielle Baird, Terra Redd, Ryan P Moore, Leena Choi, Autumn D Zuckerman

Am J Health Syst Pharm· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ustekinumab infusion to subcutaneous transition: Coordinating care and identifying potential gaps.
Chelsea P Renfro, Jessica Fann, Josh DeClercq, Rachael D Baggett, Patrick Nichols, Autumn D Zuckerman

J Manag Care Spec Pharm· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deutetrabenazine treatment outcomes with doses above U.S. Food and Drug Administration maximum approved doses in Huntington's disease chorea: A dual-site analysis.
Kayla Dodson, Sabrina Livezey, Brittany Denson, Leena Choi, Josh DeClercq, Autumn D Zuckerman

J Huntingtons Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deprescribing 5-Aminosalicytes in Patients with Ulcerative Colitis on Concomitant Advanced Therapy: A Qualitative Analysis.
Katie R Cruchelow, Kemberlee R Bonnet, Autumn D Zuckerman, David G Schlundt, Sara N Horst

Patient Prefer Adherence· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacist tailored monitoring for patients initiating encorafenib and binimetinib combination therapy.
Brooke D Looney, Stephanie G White, Josh DeClercq, Autumn D Zuckerman, Leena Choi

J Oncol Pharm Pract· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated health system pharmacy role in adherence, persistence, and adverse effect management for oral chronic lymphocytic leukemia therapy.
Houston Wyatt, Stephanie White, Hannah Holloway, Josh DeClercq, Autumn D Zuckerman

J Manag Care Spec Pharm· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Getting to specialty treatment in dermatologic inflammatory conditions: Treatment requirements and patient journey.
Matthew G Bowles, Autumn D Zuckerman, Josh DeClercq, Leena Choi, Mackenzie Ellis

J Manag Care Spec Pharm· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultra-complex specialty medications: Meeting the challenges of significant medication requirements through an integrated specialty pharmacy model.
Chelsea P Renfro, Dustin R Donald, Amanda M Kibbons, Monica D Littlejohn, E Danielle Bryan, Autumn D Zuckerman

Am J Health Syst Pharm· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A primer on copay accumulators, copay maximizers, and alternative funding programs.
David Choi, Autumn D Zuckerman, Svetlana Gerzenshtein, Katherine V Katsivalis, Patrick J Nichols

J Manag Care Spec Pharm· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating patient-reported adherence and outcomes in specialty disease states: A dual-site initiative.
E Danielle Bryan, Chelsea P Renfro, Rebekah H Anguiano, Lisa Kumor, Josh DeClercq, Autumn D Zuckerman

J Manag Care Spec Pharm· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraining transplant pharmacy staff to reduce Medicare Part B prescription billing errors post-transplant.
Keren Rodriguez, Chelsea Ray, Kirsten Mitchell, Sarah Osman, Carey Vallone, Autumn D Zuckerman

J Am Pharm Assoc (2003)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Financial impact of integrated specialty pharmacy efforts to avoid oral anticancer medication waste.
Brooke Looney, Jared Crumb, Stephanie White, Gabrielle Jones, Ryan P Moore, Autumn D Zuckerman

J Manag Care Spec Pharm· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost avoidance from health system specialty pharmacist interventions in patients with multiple sclerosis.
Darina Georgieva, Brandon Markley, Josh DeClercq, Leena Choi, Autumn D Zuckerman

J Manag Care Spec Pharm· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent use of dupilumab in adults with asthma or chronic rhinosinusitis with nasal polyps.
Kristen B Corey, Ryan Moore, Autumn D Zuckerman, Monica Littlejohn, Katherine N Cahill

Ann Allergy Asthma Immunol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence and discontinuation of prescription cannabidiol for the management of seizure disorders at an integrated care center.
J Paige Barnes, Holly Dial, Wendi Owens, Josh DeClercq, Leena Choi, Autumn D Zuckerman

Epilepsy Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insurance Approval Delay of Biologic Therapy Dose Escalation Associated with Disease Activity in Patients with Inflammatory Bowel Disease.
Nisha B Shah, Autumn D Zuckerman, Katie R Hosteng, Jessica Fann, Josh DeClercq

Dig Dis Sci· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing HIV PrEP Persistence: Does Your Pharmacy Matter?
Kristen Whelchel, Autumn D Zuckerman, Josh DeClercq, Leena Choi, Sean G Kelly

AIDS Behav· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes and pharmacist actions in patients with multiple sclerosis managed by health-system specialty pharmacies.
Autumn D Zuckerman, Aimee M Banks, Julie Wawrzyniak, Elizabeth Rightmier, Dana Simonson

Am J Health Syst Pharm· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy outcomes associated with prescription cannabidiol use at 12 months post-initiation.
Kayla Johnson, Jessica P Barnes, Holly Dial, Josh DeClercq, Leena Choi, Autumn D Zuckerman

Epilepsy Behav· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence and persistence to self-administered disease-modifying therapies in patients with multiple sclerosis: A multisite analysis.
Autumn D Zuckerman, Josh DeClercq, Dana Simonson, Alicia L Zagel, Evan Turco

Mult Scler Relat Disord· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health Insurer Strategies to Reduce Specialty Drug Spending-Copayment Adjustment and Alternative Funding Programs.
Autumn D Zuckerman, Megan P Schneider, Stacie B Dusetzina

JAMA Intern Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary medication nonadherence rates to specialty disease-modifying antirheumatic drugs for rheumatoid arthritis within a health system specialty pharmacy.
Laura Petry, Autumn D Zuckerman, Josh DeClercq, Leena Choi, Bridget Lynch

J Manag Care Spec Pharm· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis